336 related articles for article (PubMed ID: 12515780)
1. Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver.
Craib KJ; Spittal PM; Wood E; Laliberte N; Hogg RS; Li K; Heath K; Tyndall MW; O'Shaughnessy MV; Schechter MT
CMAJ; 2003 Jan; 168(1):19-24. PubMed ID: 12515780
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver.
Spittal PM; Craib KJ; Wood E; Laliberté N; Li K; Tyndall MW; O'Shaughnessy MV; Schechter MT
CMAJ; 2002 Apr; 166(7):894-9. PubMed ID: 11949985
[TBL] [Abstract][Full Text] [Related]
3. Baseline self-perceived risk of HIV infection independently predicts the rate of HIV seroconversion in a prospective cohort of injection drug users.
Wood E; Li K; Miller CL; Hogg RS; Montaner JS; Schechter MT; Kerr T
Int J Epidemiol; 2005 Feb; 34(1):152-8. PubMed ID: 15561747
[TBL] [Abstract][Full Text] [Related]
4. Binge drug use independently predicts HIV seroconversion among injection drug users: implications for public health strategies.
Miller CL; Kerr T; Frankish JC; Spittal PM; Li K; Schechter MT; Wood E
Subst Use Misuse; 2006; 41(2):199-210. PubMed ID: 16393742
[TBL] [Abstract][Full Text] [Related]
5. Burden of HIV infection among aboriginal injection drug users in Vancouver, British Columbia.
Wood E; Montaner JS; Li K; Zhang R; Barney L; Strathdee SA; Tyndall MW; Kerr T
Am J Public Health; 2008 Mar; 98(3):515-9. PubMed ID: 18235063
[TBL] [Abstract][Full Text] [Related]
6. Rate of methadone use among Aboriginal opioid injection drug users.
Wood E; Montaner JS; Li K; Barney L; Tyndall MW; Kerr T
CMAJ; 2007 Jul; 177(1):37-40. PubMed ID: 17606937
[TBL] [Abstract][Full Text] [Related]
7. Requiring help injecting independently predicts incident HIV infection among injection drug users.
O'Connell JM; Kerr T; Li K; Tyndall MW; Hogg RS; Montaner JS; Wood E
J Acquir Immune Defic Syndr; 2005 Sep; 40(1):83-8. PubMed ID: 16123687
[TBL] [Abstract][Full Text] [Related]
8. Slower uptake of HIV antiretroviral therapy among Aboriginal injection drug users.
Wood E; Kerr T; Palepu A; Zhang R; Strathdee SA; Tyndall MW; Montaner JS; Hogg RS
J Infect; 2006 Apr; 52(4):233-6. PubMed ID: 16169594
[TBL] [Abstract][Full Text] [Related]
9. The future face of coinfection: prevalence and incidence of HIV and hepatitis C virus coinfection among young injection drug users.
Miller CL; Wood E; Spittal PM; Li K; Frankish JC; Braitstein P; Montaner JS; Schechter MT
J Acquir Immune Defic Syndr; 2004 Jun; 36(2):743-9. PubMed ID: 15167294
[TBL] [Abstract][Full Text] [Related]
10. The impact of sex partners' HIV status on HIV seroconversion in a prospective cohort of injection drug users.
Kerr T; Stoltz JA; Strathdee S; Li K; Hogg RS; Montaner JS; Wood E
J Acquir Immune Defic Syndr; 2006 Jan; 41(1):119-23. PubMed ID: 16340484
[TBL] [Abstract][Full Text] [Related]
11. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
[TBL] [Abstract][Full Text] [Related]
12. Predictors of syphilis seroreactivity and prevalence of HIV among street recruited injection drug users in Los Angeles County, 1994-6.
López-Zetina J; Ford W; Weber M; Barna S; Woerhle T; Kerndt P; Monterroso E
Sex Transm Infect; 2000 Dec; 76(6):462-9. PubMed ID: 11221130
[TBL] [Abstract][Full Text] [Related]
13. Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection.
Patrick DM; Tyndall MW; Cornelisse PG; Li K; Sherlock CH; Rekart ML; Strathdee SA; Currie SL; Schechter MT; O'Shaughnessy MV
CMAJ; 2001 Oct; 165(7):889-95. PubMed ID: 11599327
[TBL] [Abstract][Full Text] [Related]
14. Hospital utilization and costs in a cohort of injection drug users.
Palepu A; Tyndall MW; Leon H; Muller J; O'Shaughnessy MV; Schechter MT; Anis AH
CMAJ; 2001 Aug; 165(4):415-20. PubMed ID: 11531049
[TBL] [Abstract][Full Text] [Related]
15. Effect of low-threshold methadone maintenance therapy for people who inject drugs on HIV incidence in Vancouver, BC, Canada: an observational cohort study.
Ahamad K; Hayashi K; Nguyen P; Dobrer S; Kerr T; Schütz CG; Montaner JS; Wood E
Lancet HIV; 2015 Oct; 2(10):e445-50. PubMed ID: 26423652
[TBL] [Abstract][Full Text] [Related]
16. The Cedar Project: high incidence of HCV infections in a longitudinal study of young Aboriginal people who use drugs in two Canadian cities.
Spittal PM; Pearce ME; Chavoshi N; Christian WM; Moniruzzaman A; Teegee M; Schechter MT
BMC Public Health; 2012 Aug; 12():632. PubMed ID: 22877418
[TBL] [Abstract][Full Text] [Related]
17. High HIV incidence in a cohort of male injection drug users in Delhi, India.
Sarna A; Saraswati LR; Sebastian M; Sharma V; Madan I; Lewis D; Pulerwitz J; Thior I; Tun W
Drug Alcohol Depend; 2014 Jun; 139():106-14. PubMed ID: 24768060
[TBL] [Abstract][Full Text] [Related]
18. Risk indicators associated with injection drug use in the Aboriginal population.
Lemstra M; Rogers M; Thompson A; Moraros J; Buckingham R
AIDS Care; 2012; 24(11):1416-24. PubMed ID: 22292863
[TBL] [Abstract][Full Text] [Related]
19. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic.
Tyndall MW; Currie S; Spittal P; Li K; Wood E; O'Shaughnessy MV; Schechter MT
AIDS; 2003 Apr; 17(6):887-93. PubMed ID: 12660536
[TBL] [Abstract][Full Text] [Related]
20. Sex differences in risk factors for hiv seroconversion among injection drug users: a 10-year perspective.
Strathdee SA; Galai N; Safaiean M; Celentano DD; Vlahov D; Johnson L; Nelson KE
Arch Intern Med; 2001 May; 161(10):1281-8. PubMed ID: 11371255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
